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A high-level review was conducted of the literature pertaining to the challenges and opportunities for eliminating malaria on the African 
continent. Although malaria mortality and morbidity are on the decline, the disease remains one of public health importance. Africa has 
invariably borne the brunt of the disease, recording the highest number of cases and deaths. However, with greater emphasis being placed 
on the disease by the international community, partnerships have developed to boost malaria elimination efforts on the continent. One 
such initiative is the Roll Back Malaria (RBM) partnership which aims to facilitate malaria elimination through increasing resources and 
awareness. Many cross-border initiatives have been established which treat malaria as a regional problem rather than a country-specific one. 
Accelerated malaria control efforts have led to a 37% decrease in cases and 60% reduction in deaths. Multi-country efforts have resulted in 
marked reductions of transmission in the region. Although there have been noteworthy gains in curtailing the disease, new challenges have 
arisen. The main among these are residual malaria and outdoor biting. One of the main drivers of residual malaria is insecticide resistance. 
Adding to the burden of residual transmission is the discovery of new vectors that may exist at low densities. To exacerbate these issues is the 
challenge of malaria imported from high- to low-transmission areas. Nevertheless, compared with the historical picture, we are winning the 
battle against malaria. Countries in Africa are being certified malaria-free. Partnerships have been developed to take forward the RBM Global 
Malaria Action Plan. Elimination agendas can only be successful if funding remains sustainable, with greater reliance on domestic funding.
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About 90% of all malaria deaths in the world occur in sub-Saharan 
Africa, where the most dangerous parasite, Plasmodium falciparum, 
is spread by Anopheles gambiae, the most efficient vector.[1] Malaria 
and underdevelopment are closely intertwined. Over 40% of the 
world’s population live where there is a risk of malaria.[1] The disease 
causes widespread premature death and suffering, imposes financial 
hardship on poor households, and impedes socio-economic growth.[2] 
Malaria is directly responsible for one in five childhood deaths in 
Africa.[1] Though malaria remains a major challenge, huge progress 
has been made since the beginning of the century; its recent 
resurgence in Africa contrasts dramatically with the global decline in 
mortality since 1900.
World War II encouraged the development of new tools for the 
control of malaria in Africa, such as choloroquine[3] and DDT.[4] The 
potential of these innovations was realised when the World Health 
Organization (WHO) proposed the Global Malaria Elimination 
(GMEP) programme in 1955.[5] However, in 1969 the WHO 
decided that sub-Saharan Africa was not ready for the elimination 
programme.[6] The WHO concluded that the protracted transmission 
season, combined with the high degree of malaria endemicity in 
the region, rendered Africa unreceptive to a large-scale eradication 
programme. African programmes were thus designed to control 
rather than eliminate the disease. At this stage, indoor residual 
spraying (IRS) was the only vector control strategy and already 
there was mounting resistance to all classes of insecticides. During 
the mid-1980s, insecticide-treated bed nets were widely distributed 
at a time when chloroquine efficacy was rapidly diminishing.[7,8] 
Following the failure of GMEP in Africa, four decades passed before 
malaria in Africa took centre stage in the international public health 
arena, especially in terms of financing.[9] The WHO recognised 
that concerted action would be required to control malaria on 
the continent and that malaria could no longer be addressed as a 
country-specific problem but rather as a regional issue.[10] Malaria 
control strategies were harmonised in the region so that a concerted 
effort could be made to push back the frontiers of malaria and to 
eventually eliminate the disease from the continent.
Malaria can be prevented, diagnosed and treated with a 
combination of available tools, but decreasing malaria transmission 
requires global commitment. Recently, co-ordinated action by 
organisations and countries has successfully mitigated the impact 
of malaria. One of the oldest such initiatives, the Roll Back Malaria 
(RBM) partnership, was launched in 1998 by the WHO with 
the goal of providing a co-ordinated global approach to fighting 
malaria. The RBM mobilises resources for action and forges 
consensus among partners. Partners, such as the Elimination 8 (E8) 
in southern Africa, have joined forces to accelerate malaria control 
measures at country level, co-ordinating their activities to exclude 
any form of duplication and fragmentation and to ensure optimum 
usage of the resources (Fig. 1). Thus, early diagnosis and prompt 
treatment with an effective drug, as well as efficacious vector 
control and enhanced surveillance, are being recommended.
There has been a concerted international effort since the early 
2000s to tackle malaria, which has led to dramatic reductions in the 
disease, especially in southern Africa (Fig. 2). WHO estimates show 
that in 2015 there were 212 million malaria cases and 439 000 deaths 
globally – a 37% decrease in the incidence of malaria compared 
with 15 years ago, and a 60% reduction in deaths. Most of the gains 
occurred in Asia and at the periphery of distribution of the disease 
in Africa. However, a challenge is that sub-Saharan Africa still 
shoulders 90% of existing cases and 92% of deaths from the disease. 
It is encouraging that 34 countries are poised for the elimination 
programme, many of them on the African continent. In the next 
10 years, South Africa’s (SA) neighbouring countries should have 
eliminated malaria.
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In the present review we focus on the 
literature that highlights the challenges 
towards achieving elimination and 
sustaining the impact attained, as well as 
the lessons learnt from countries that have 
already achieved elimination.
Methodology
This is not intended to be a systematic 
review, but rather aims to present the 
challenges that need to be overcome 
and the successes that have been made 
in achieving malaria elimination. The 
research question therefore was twofold: 
firstly, to examine the hurdles that are 
preventing elimination from being 
achieved and, secondly, to highlight the 
successes that have already been attained. 
As the subject of this review is quite 
topical, a literature search was completed 
using PubMed to find articles addressing 
the research questions. When available, SA 
literature was included.
Results and discussion
The articles selected underline the 
impediments that are preventing attainment 
of the elimination goal, as well as the 
sustainability of gains that have already been 
achieved. As some countries in Africa have 
already achieved elimination, the lessons 
to be learnt from these successes are also 
summarised.
Multi-country efforts to eliminate 
malaria
Malaria is a regional problem and not 
a country-specific one; therefore, 
what happens in one country affects 
neighbouring countries. This was the 
premise under which the Lubombo 
Spatial Development Initiative (LSDI) 
was developed between Mozambique, SA 
and Swaziland (now known as eSwatini). 
Through implementing evidence-based 
vector control and case management, 
malaria prevalence in Mozambique 
decreased by 80% while the incidence 
in SA and Swaziland decreased by 98%, 
so enabling these countries to adopt an 
elimination agenda.[11]
Following the achievement of the LSDI, the 
MoSaSwa (Mozambique, SA and Swaziland) 
initiative was built on the platform developed 
by the LSDI[12] and it has already had a great 
impact on the disease burden in southern 
Mozambique, enabling the country to target 
elimination by 2030. The Trans-Kunene 
Malaria Initiative between Namibia and 
Angola has successfully reduced malaria 
in their border regions. A smaller initiative 
between Zimbabwe and Zambia (Zim-Zam) 
has been instrumental in reducing malaria 
in the border areas of these two countries. 
All these initiatives have contributed 
to significantly decreasing the burden 
of disease in the participating countries, 
thus paving the way for elimination by 
2030. Malaria elimination efforts in the 8 
southernmost African countries are being 
facilitated by the E8 initiative to enable and 
accelerate zero local transmission in the 
4 frontline countries (Botswana, Namibia, 
SA, Swaziland) by 2020 and the second-line 
countries (Angola, Mozambique, Zambia, 
Zimbabwe) by 2030 through the provision 
of a joint platform for collaboration and joint 
strategic programming.[13]
Challenges for elimination
Residual malaria
The sustained use of long-lasting 
insecticidal nets (LLINs) and IRS has 
reduced malaria transmission. However, 
these interventions are only effective when 
the human hosts are indoors; they afford 
no protection to individuals outside their 
homes. Insecticide-induced avoidance of 
contact with treated surfaces within houses 
and early exit from them, minimises 
exposure of vectors which feed indoors 
upon humans.[14] Vectors are opportunistic, 
and able to feed upon animals, thus avoiding 
contact with IRS insecticides. Behaviour 
modification occurs in mosquitoes, causing 
them to rest outdoors and avoid contact 
with insecticide-treated surfaces of nets 
and walls, enabling low-level transmission. 
Residual malaria transmission is therefore 
defined as all forms of transmission that 
can persist after achieving full universal 
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Fig. 2. Malaria cases reported for E8 countries from 1999 - 2017 (numbers above columns indicate 
number of countries providing data).
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Fig. 1. Malaria cases reported for E8 countries from 1988 - 1998 (numbers above columns indicate 
number of countries providing data).
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coverage with effective malaria control interventions.[15] Residual 
transmission is a significant challenge to ongoing malaria 
elimination efforts, owing to insecticide and drug resistance, and 
novel tools are required to overcome these challenges. According 
to Killeen,[15] the issue of residual malaria can be addressed by 
novel or improved vector control strategies that address residual 
transmission. Such strategies enhance control of vectors that enter 
houses to feed and/or rest by killing, repelling or excluding them.
Outdoor transmission
In response to the insecticidal pressure from long-term use of IRS 
and LLINs, vectors have modified their behaviour to avoid contact 
with insecticides.[16] In order to feed before their hosts go indoors, 
mosquitoes are now biting earlier and outdoors. This is a major 
setback, as the main interventions provide protection to people only 
within IRS-sprayed houses or those sleeping under a bednet. To 
overcome this problem, larval source management is advocated as 
one strategy. Studies in Kenya[17] indicate that outdoor baited traps 
can divert mosquitoes from feeding on people to entering these traps. 
Further studies need to be conducted to identify ways of overcoming 
outdoor transmission.
Insecticide and drug resistance
Major drivers of residual malaria are vector resistance to insecticides 
and parasite resistance to antimalaria drugs. Resistance has been 
reported to all classes of insecticides currently approved by the WHO 
for use in IRS programmes. The most widespread resistance is to 
pyrethroid insecticides in terms of geography and species of vectors. 
However, there are new insecticide classes and insecticide mixtures 
that have shown potential for replacing DDT, which is the current 
gold standard.[18,19] The main drawback of the new insecticides is the 
cost of purchasing them as well as their application.
Drug resistance is also on the increase, beginning in the early 
1980s with resistance to chloroquine, followed by resistance to 
sulfadoxine-pyrimethamine in the mid- to late 1990s. Artemisinin-
based combination therapy (ACT) was introduced into Africa in 
2004 in Zambia for the first time and has since become the drug of 
choice for the management of malaria infections. There is already 
widespread tolerance to ACT in Myanmar and Thailand[20] and the 
potential for resistance to artemisinin has been identified in Angola.[21] 
The efficacy of currently available ACTs is diminishing and there is 
no existing replacement drug. There is a potential new drug that has 
been identified by researchers funded by the South African Medical 
Research Council (SAMRC) that has gone into first-in-man studies.
New vectors
One of the factors contributing to residual malaria is the unknown 
role of secondary vectors. Traditional malaria control tools have 
targeted only Anopheles gambiae s.s, An. arabiensis and An. funestus. 
Targeting control measures at the three species has resulted in huge 
reductions in the burden of disease. However, new vectors have 
in recent times been identified.[22] It may also be that these new 
vectors which feed and rest outdoors, contribute to very low levels 
of transmission.
Imported malaria
Imported malaria has been described as an infection that was 
acquired in an endemic area by an individual (either a tourist or 
local) but diagnosed in a non-endemic country after development 
of the clinical disease.[23] Currently, the biggest threat to elimination 
efforts are the risk of resurgence of malaria owing to imported cases. [24] 
Given the high receptivity to malaria in previously endemic areas 
of the country owing to prevalence of the vector mosquito, such 
cases pose a significant threat for the reintroduction of malaria to 
malaria-free areas. These cases occur via infected people entering the 
country and becoming ill on arrival, or vehicles returning from high-
transmission countries with malaria-infected mosquitoes that cause 
outbreaks in the destination areas.
Sustaining the gains
Although Africa has historically had a high transmission rate,[25] 
southern Africa has nevertheless been particularly successful in 
reducing its case load over the past decade (Fig. 2). The Seychelles 
and Mauritius have eliminated malaria, as they have had no new 
local transmissions in recent years.[26] This reflects reductions in 
several of SA’s neighbouring countries such as Botswana, Namibia 
and Swaziland, where malaria mortality rates are close to zero. In 
SA, there was a significant peak of 64 622 cases in 2000. Since then, 
case numbers have dwindled to between 6 000 and 10 000 in recent 
years. However, in the past two seasons, large numbers of cases were 
reported from the southern African region, most notably in the E8 
countries (Fig. 2).[13]
In 2015, there were roughly 212 million malaria cases and an 
estimated 439 000 malaria deaths. [27] Increased prevention and 
control measures have led to a 29% reduction in malaria mortality 
rates globally since 2010. Sub-Saharan Africa continues to carry a 
disproportionately high share of the global malaria burden. In 2015, 
the region was home to 90% of malaria cases and 92% of malaria 
deaths. In the past 15 years, there has been tremendous progress at 
a global level in the fight against malaria. According to the World 
Malaria Report,[28] malaria case incidence reduced by 41% and 
malaria mortality rates reduced by 62% between 2000 and 2015. [27] 
At the beginning of 2016, malaria was endemic in 91 countries and 
territories, down from 108 in 2000. [29] Despite this progress, malaria 
continues to exact a heavy toll.
Over the past three decades, there has been a dramatic decrease in 
the number of cases and deaths due to malaria. Only 5 countries on the 
African continent and 3 of the Indian Ocean Islands have been certified 
free of malaria by the WHO. [26] Botswana, Namibia, SA and Swaziland 
are likely to achieve zero local transmission in the next 5 years. The 
lessons learnt with regards to cross-border collaboration in SA and 
its neighbouring countries are of great importance and there is some 
urgency in cementing these successes. [11,12]
To sustain the gains made, especially when elimination has been 
achieved, is when the real challenges will emerge, the most important 
being sustainable funding in achieving the goal of elimination. 
Entering the eradication phase is a relatively new frontier for African 
countries, and a major concern is continued political support and 
donor fatigue. Countries reliant on international donor support will 
be most affected – and these are high-transmission countries such 
as Mozambique and Tanzania. The moment when control measures 
weaken, malaria is likely to rebound rapidly in the face of migration 
and importation from high-transmission neighbouring countries that 
are still fighting to bring malaria under control. This was the scenario 
in Sri Lanka in 1963[30] and Mauritius in 1975,[31] where malaria 
rebounded after cases had dropped to nearly zero.
Conclusion
Although there have been remarkable achievements in decreasing 
the burden of malaria in Africa, many barriers need to be overcome 
to reach elimination. This goal will require ongoing research to 
fill the knowledge gaps identified. With many countries targeting 
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elimination by 2030, there is a need to overcome the challenges facing 
the elimination agenda and to sustain the gains already attained. To 
address the elimination agenda, it is necessary to lobby for sustainable 
domestic funding to ensure that the disease does not rebound 
because of lack of resources. Also, cross-border initiatives need to be 
strengthened to pave the way for elimination and in preparation for 
the prevention of reintroduction once elimination is achieved.
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